Addition of ovarian function suppression to endocrine therapy in premenopausal women with early breast cancer: A meta-analysis

被引:0
|
作者
Chlebowski, R. [1 ,2 ]
Pan, K.
Col, N. F.
机构
[1] Los Angeles BioMed Res Inst, Harbor UCLA Med Ctr, Torrance, CA 90509 USA
[2] Univ New England, Portland, ME USA
关键词
D O I
10.1158/1538-7445.SABCS16-P2-09-06
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P2-09-06
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Ovarian suppression in combination endocrine adjuvant therapy in premenopausal women with early breast cancer
    Paola Muti
    Giorgio Secreto
    Vittorio Krogh
    [J]. Breast Cancer Research and Treatment, 2017, 163 : 631 - 632
  • [2] Ovarian function suppression and fulvestrant as endocrine therapy in premenopausal women with metastatic breast cancer
    Bartsch, Rupert
    Bago-Horvath, Zsuzsanna
    Berghoff, Anna
    DeVries, Catharina
    Pluschnig, Ursula
    Dubsky, Peter
    Rudas, Margaretha
    Mader, Robert M.
    Rottenfusser, Andrea
    Fitzal, Florian
    Gnant, Michael
    Zielinski, Christoph C.
    Steger, Guenther G.
    [J]. EUROPEAN JOURNAL OF CANCER, 2012, 48 (13) : 1932 - 1938
  • [3] Ovarian suppression in combination endocrine adjuvant therapy in premenopausal women with early breast cancer
    Muti, Paola
    Secreto, Giorgio
    Krogh, Vittorio
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2017, 163 (03) : 631 - 632
  • [4] Ovarian suppression in combination endocrine adjuvant therapy in premenopausal women with early breast cancer
    Rowan T. Chlebowski
    Kathy Pan
    Nananda F. Col
    [J]. Breast Cancer Research and Treatment, 2017, 161 : 185 - 190
  • [5] Ovarian suppression in combination endocrine adjuvant therapy in premenopausal women with early breast cancer
    Chlebowski, Rowan T.
    Pan, Kathy
    Col, Nananda F.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2017, 161 (02) : 185 - 190
  • [6] Ovarian suppression in combination endocrine adjuvant therapy in premenopausal women with early breast cancer Response
    Chlebowski, Rowan T.
    Pan, Kathy
    Nananda, F.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2017, 163 (03) : 633 - 634
  • [7] Role of Ovarian Function Suppression in Premenopausal Women with Early Breast Cancer
    Park, Woo-Chan
    [J]. JOURNAL OF BREAST CANCER, 2016, 19 (04) : 341 - 348
  • [8] Adjuvant ovarian function suppression and tamoxifen in premenopausal breast cancer patients: A meta-analysis
    Azim, Hamdy A.
    Shohdy, Kyrillus S.
    Kaldas, David F.
    Kassem, Loay
    Azim, Hatem A., Jr.
    [J]. CURRENT PROBLEMS IN CANCER, 2020, 44 (06)
  • [9] Tamoxifen versus anastrozole as adjuvant therapy in early stage breast cancer in premenopausal women on ovarian function suppression: A meta-analysis of randomized clinical trials
    Sidahmed, Shima
    Abdalla, Ahmed
    Kheiri, Babikir
    Bachuwa, Ghassan
    [J]. CANCER RESEARCH, 2020, 80 (04)
  • [10] Ovarian Suppression in Adjuvant Endocrine Therapy for Premenopausal Breast Cancer
    Pan, Kathy
    Bosserman, Linda Diana
    Chlebowski, Rowan T.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (11) : 858 - +